LAUREN MARTIN: Open Payments
NPI 1821553959 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 23 payments from 9 companies in 2025. Trend: 2023 $201 · 2024 $84 · 2025 $457
Food & beverage: $443Education: $13
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $175 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Lundbeck LLC | 2 | $37 |
| Calliditas Therapeutics US Inc. | 1 | $37 |
| Amgen Inc. | 2 | $36 |
| Aurinia Pharma U.S., Inc. | 2 | $36 |
| Travere Therapeutics, Inc. | 3 | $32 |
| Ardelyx, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $17 |
Products named: REXULTI, TARPEYO, TAVNEOS, LUPKYNIS, JYNARQUE, IBSRELA, JARDIANCE, BREZTRI.
Industry payments across TN — which companies pay providers there.
